Compare MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MONDELEZ INTERNATIONAL INC Common Stock vs Teladoc Health Inc — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $59.21 (market cap $77.37B), while Teladoc Health Inc trades at $9.7 (market cap $1.74B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 44.5× Teladoc Health Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.32% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| MDLZ | TDOC | |
|---|---|---|
Market Cap | $77.37B | $1.74B |
Sector | Consumer Staples | Health |
52-Week High | $70.75 | $9.72 |
52-Week Low | $51.51 | $4.47 |
Enterprise Value | $97.46B | $2.03B |
Dividend Yield | 3.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mondelez International (MDLZ) trades at $59.86, down 1.87% today but maintains a bullish technical signal with strong moving average support. The company reported Q1 2026 EPS of $0.67, beating expectations, and shows consistent revenue growth reaching $38.54B in 2025. Analyst consensus is strongly bullish with a $68.00 price target, representing 13.6% upside potential from current levels.
MDLZ offers stable dividend income and brand strength but faces margin compression risks from input cost inflation. The upcoming Q2 2026 earnings report on July 28, 2026 serves as the next major catalyst. While valuation multiples appear elevated, the company's market leadership and innovation pipeline support long-term growth prospects despite near-term profitability challenges.
TDOC trades at $9.71, up 2.97% with a bullish technical signal. The stock shows improving fundamentals with revenue stabilizing around $2.5B and narrowing losses. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026. Positive sentiment is driven by partnerships like Walmart Better Care and cost-cutting initiatives, though net margins remain negative.
The outlook suggests cautious optimism as operational improvements may drive recovery, but persistent losses and high debt pose risks. Analyst consensus is mixed with 36% buy ratings and a $9.50 price target, indicating limited upside. Investors should weigh cost-control progress against competitive pressures in telehealth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
